FFAR2 and asthma: Activation of GPR43 and GPR41 by propionate could thus possibly have a protective effect on inflammation in asthma by promoting a tolerogenic DC phenotype and reducing the recruitment of immune cells, pointing to a potential role of HMOs as a source for SCFA production.